Zim Laboratories: The financial results for the period ended September 30, 2026
Zim Laboratories (ZIMLAB) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹715 crore.
What happened
Zim Laboratories (ZIMLAB) filed a disclosure with the exchanges on 4 November 2026 at 02:36 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Zim Laboratories is a micro-cap company, with a market value of about ₹715 crore.
The stock last traded at ₹133.5, against a 52-week range of ₹59.31–₹159.8 (16.5% below the high).
Before this filing the shares had moved +3.9% over the month and +30.6% over three months. Average daily turnover over the last 20 sessions was about ₹2.64 crore.
Promoters held 30.36% at the end of Q1 FY27. Foreign institutions owned 0.03% and domestic institutions 1.33%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 72 | -1.9 | -0.38 |
| Q2 FY26 | 89 | -0.4 | -0.09 |
| Q3 FY26 | 109 | 4.4 | 0.9 |
| Q4 FY26 | 105 | 3.7 | 0.76 |
| Q1 FY27 | 94 | -4 | -0.75 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.